Skip to main content
Erschienen in: World Journal of Surgery 1/2006

01.01.2006

Surgical Management of Small Gastrointestinal Stromal Tumors of the Stomach

verfasst von: Makoto Iwahashi, MD, Katsunari Takifuji, MD, Toshiyasu Ojima, MD, Masaki Nakamura, MD, Mikihito Nakamori, MD, Yoshihiro Nakatani, MD, Kentaro Ueda, MD, Koichiro Ishida, MD, Teiji Naka, MD, Kazuo Ono, MD, Hiroki Yamaue, MD

Erschienen in: World Journal of Surgery | Ausgabe 1/2006

Einloggen, um Zugang zu erhalten

Abstract

Small gastrointestinal stromal tumors (GISTs) (<3 cm) occasionally are found in the stomach during endoscopy. There is no consensus about the surgical management of these small tumors, although this clinical issue is crucial because some of the tumors show unexpected malignant behavior. In this study, we evaluated the clinical management of patients with gastric GISTs who underwent surgical resection. Altogether, 31 patients with gastric GISTs were examined retrospectively. Surgical resection was fundamentally indicated for the patients with gastric GISTs suspected to be malignant by endoscopy or endoscopic ultrasonography (EUS). The malignant grade of the GISTs was evaluated by the mitotic rate, tumor size, and MIB-1 index. EUS was useful for differentiating benign from malignant GISTs; but by limiting the study to patients with small tumors (<3 cm), the diagnostic value of EUS was not satisfactory for defining the surgical indication. Tumors that were <50 mm were successfully treated by laparoscopic surgery. Of the 31 patients, 4 had a relapse of the disease, and 1 of those 4 patients had a small tumor (30 mm). All of the recurrences were classified in the high risk category. Surgery is indicated for gastric GISTs that are ≥20 mm or are suspected to be malignant based on EUS findings. Laparoscopic resection is feasible and is recommended as the treatment of choice for patients with tumors < 50 mm. Risk assessment can be most useful for predicting recurrence.
Literatur
1.
Zurück zum Zitat Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577–580PubMedCrossRef Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577–580PubMedCrossRef
2.
Zurück zum Zitat Sircar K, Hewlett BR, Huizinga JD, et al. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999;23:377–389PubMedCrossRef Sircar K, Hewlett BR, Huizinga JD, et al. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors. Am J Surg Pathol 1999;23:377–389PubMedCrossRef
3.
Zurück zum Zitat Pidhorecky I, Cheney RT, Kraybill WG, et al. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000;7:705–712PubMed Pidhorecky I, Cheney RT, Kraybill WG, et al. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann Surg Oncol 2000;7:705–712PubMed
4.
Zurück zum Zitat Seidal T, Edvardsson H. Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours. Histopathology 1999;34:416–424PubMedCrossRef Seidal T, Edvardsson H. Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours. Histopathology 1999;34:416–424PubMedCrossRef
5.
Zurück zum Zitat Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459–465PubMed Fletcher CDM, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol 2002;33:459–465PubMed
6.
Zurück zum Zitat Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal tumors. Lancet Oncol 2002;3:655–664PubMedCrossRef Joensuu H, Fletcher C, Dimitrijevic S, et al. Management of malignant gastrointestinal stromal tumors. Lancet Oncol 2002;3:655–664PubMedCrossRef
7.
Zurück zum Zitat Kimata M, Kubota T, Otani Y, et al. Gastrointestinal stromal tumors treated by laparoscopic surgery: report of three cases. Surg Today 2000;30:177–180PubMedCrossRef Kimata M, Kubota T, Otani Y, et al. Gastrointestinal stromal tumors treated by laparoscopic surgery: report of three cases. Surg Today 2000;30:177–180PubMedCrossRef
8.
Zurück zum Zitat Basso N, Rosato P, De Leo A, et al. Laparoscopic treatment of gastric stromal tumors. Surg Endosc 2000;14:524–526PubMed Basso N, Rosato P, De Leo A, et al. Laparoscopic treatment of gastric stromal tumors. Surg Endosc 2000;14:524–526PubMed
9.
Zurück zum Zitat Walsh RM, Ponsky J, Brody F, et al. Combined endoscopic/laparoscopic intragastric resection of gastric stromal tumors. J Gastrointest Surg 2003;7:386–392PubMed Walsh RM, Ponsky J, Brody F, et al. Combined endoscopic/laparoscopic intragastric resection of gastric stromal tumors. J Gastrointest Surg 2003;7:386–392PubMed
10.
Zurück zum Zitat Amin MB, Ma CK, Linden MD, et al. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Am J Clin Pathol 1993;100:428–432PubMed Amin MB, Ma CK, Linden MD, et al. Prognostic value of proliferating cell nuclear antigen index in gastric stromal tumors. Am J Clin Pathol 1993;100:428–432PubMed
11.
Zurück zum Zitat Taniguchi E, Kamiike W, Yamanishi H, et al. Laparoscopic intragastric surgery for gastric leiomyoma. Surg Endosc 1997;11:287–289PubMed Taniguchi E, Kamiike W, Yamanishi H, et al. Laparoscopic intragastric surgery for gastric leiomyoma. Surg Endosc 1997;11:287–289PubMed
12.
Zurück zum Zitat Chak A, Canto MI, Rosch T, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastroenterol. Endosc.1997;45:468–473 Chak A, Canto MI, Rosch T, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastroenterol. Endosc.1997;45:468–473
13.
Zurück zum Zitat Yasuda K, Nakajima M, Yoshida S, et al. The diagnosis of submucosal tumors of the stomach by endoscopic ultrasonography. Gastroenterol Endosc 1989;35:10–15 Yasuda K, Nakajima M, Yoshida S, et al. The diagnosis of submucosal tumors of the stomach by endoscopic ultrasonography. Gastroenterol Endosc 1989;35:10–15
14.
Zurück zum Zitat Rosch T, Lorenz R, Dancygier H, et al. Endosonographic diagnosis of submucosal upper gastrointestinal tract tumors. Scand J Gastroenterol 1992;27:1–8PubMed Rosch T, Lorenz R, Dancygier H, et al. Endosonographic diagnosis of submucosal upper gastrointestinal tract tumors. Scand J Gastroenterol 1992;27:1–8PubMed
15.
Zurück zum Zitat Yamada Y, Kida M, Sakaguchi T. A study on myogenic tumors of the upper gastrointestinal tract by endoscopic ultrasonography: with special reference to the differential diagnosis of benign and malignant lesions. Dig Endosc 1992;4:396–408 Yamada Y, Kida M, Sakaguchi T. A study on myogenic tumors of the upper gastrointestinal tract by endoscopic ultrasonography: with special reference to the differential diagnosis of benign and malignant lesions. Dig Endosc 1992;4:396–408
16.
Zurück zum Zitat Terashita S, Tanimura H, Nagai Y, et al. Clinical evaluation of endoscopic ultrasonography in the differential diagnosis for submucosal tumor of gastrointestinal tract. Gastroenterol Endosc 1992;34:342–351 Terashita S, Tanimura H, Nagai Y, et al. Clinical evaluation of endoscopic ultrasonography in the differential diagnosis for submucosal tumor of gastrointestinal tract. Gastroenterol Endosc 1992;34:342–351
17.
Zurück zum Zitat Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30:1213–1220PubMed Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999; 30:1213–1220PubMed
18.
Zurück zum Zitat Vander Noot MR 3rd, Eloubeidi MA, et al. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2004;102:157–163PubMedCrossRef Vander Noot MR 3rd, Eloubeidi MA, et al. Diagnosis of gastrointestinal tract lesions by endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 2004;102:157–163PubMedCrossRef
19.
Zurück zum Zitat Gu M, Ghafari S, Nguyen PT, Lin F. Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol 2001;25:343–350PubMedCrossRef Gu M, Ghafari S, Nguyen PT, Lin F. Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol 2001;25:343–350PubMedCrossRef
20.
Zurück zum Zitat Katai H, Sasako M, Sano T, et al. Surgical treatment for gastric leiomyosarcoma. Ann Chir Gynaecol 1998;87:293–296PubMed Katai H, Sasako M, Sano T, et al. Surgical treatment for gastric leiomyosarcoma. Ann Chir Gynaecol 1998;87:293–296PubMed
21.
Zurück zum Zitat Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus. Am J Surg Pathol 2001;25:1121–1131PubMed Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus. Am J Surg Pathol 2001;25:1121–1131PubMed
22.
Zurück zum Zitat Hasegawa T, Matsuno Y, Shimoda T, et al. Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002;33:669–676PubMed Hasegawa T, Matsuno Y, Shimoda T, et al. Gastrointestinal stromal tumor: Consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol 2002;33:669–676PubMed
23.
Zurück zum Zitat DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51–58PubMedCrossRef DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51–58PubMedCrossRef
24.
Zurück zum Zitat Lehnet T. Gastrointestinal sarcoma (GIST): a review of surgical management. Ann Chir Gynaecol 1998;87:297–305 Lehnet T. Gastrointestinal sarcoma (GIST): a review of surgical management. Ann Chir Gynaecol 1998;87:297–305
25.
Zurück zum Zitat Blanke CD, Eisenberg BL, Heinrich MC. Gastrointestinal stromal tumors. Curr. Treat. Options Oncol 2001;2:485–491 Blanke CD, Eisenberg BL, Heinrich MC. Gastrointestinal stromal tumors. Curr. Treat. Options Oncol 2001;2:485–491
26.
Zurück zum Zitat Yoshida M, Otani Y, Ohgami M, et al. Surgical management of gastric leiomyosarcoma: evaluation of the propriety of laparoscopic wedge resection. World J Surg 1997;21:440–443PubMed Yoshida M, Otani Y, Ohgami M, et al. Surgical management of gastric leiomyosarcoma: evaluation of the propriety of laparoscopic wedge resection. World J Surg 1997;21:440–443PubMed
27.
Zurück zum Zitat Kimura H, Yonemura Y, Kadoya N, et al. Prognostic factors in primary gastrointestinal leiomyosarcoma: a retrospective study. World J Surg 1991;15:771–776PubMedCrossRef Kimura H, Yonemura Y, Kadoya N, et al. Prognostic factors in primary gastrointestinal leiomyosarcoma: a retrospective study. World J Surg 1991;15:771–776PubMedCrossRef
28.
Zurück zum Zitat Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas: implications for surgical management and staging. Ann Surg 1992;215:68–77PubMedCrossRef Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas: implications for surgical management and staging. Ann Surg 1992;215:68–77PubMedCrossRef
29.
Zurück zum Zitat Toquet C, Le Neel JC, Guillou L, et al. Elevated (> or = 10%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases. Dig Dis Sci 2002;47:2247–2253PubMedCrossRef Toquet C, Le Neel JC, Guillou L, et al. Elevated (> or = 10%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases. Dig Dis Sci 2002;47:2247–2253PubMedCrossRef
30.
Zurück zum Zitat Fujimoto Y, Nakanishi Y, Yoshimura K, et al. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003;6:39–48PubMedCrossRef Fujimoto Y, Nakanishi Y, Yoshimura K, et al. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003;6:39–48PubMedCrossRef
31.
Zurück zum Zitat Özgüç H, Yilmazlar T, Yerci Ö, et al. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential. J Gastrointest Surg 2005;9:418–429PubMed Özgüç H, Yilmazlar T, Yerci Ö, et al. Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential. J Gastrointest Surg 2005;9:418–429PubMed
32.
Zurück zum Zitat Wong NA, Young R, Malcomson RD, et al. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 2003;43:118–126PubMedCrossRef Wong NA, Young R, Malcomson RD, et al. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 2003;43:118–126PubMedCrossRef
33.
Zurück zum Zitat Kim TW, Lee H, Kang YK, et al. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res 2004;10:3076–3081PubMed Kim TW, Lee H, Kang YK, et al. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. Clin Cancer Res 2004;10:3076–3081PubMed
Metadaten
Titel
Surgical Management of Small Gastrointestinal Stromal Tumors of the Stomach
verfasst von
Makoto Iwahashi, MD
Katsunari Takifuji, MD
Toshiyasu Ojima, MD
Masaki Nakamura, MD
Mikihito Nakamori, MD
Yoshihiro Nakatani, MD
Kentaro Ueda, MD
Koichiro Ishida, MD
Teiji Naka, MD
Kazuo Ono, MD
Hiroki Yamaue, MD
Publikationsdatum
01.01.2006
Erschienen in
World Journal of Surgery / Ausgabe 1/2006
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-7944-4

Weitere Artikel der Ausgabe 1/2006

World Journal of Surgery 1/2006 Zur Ausgabe

OriginalPaper

Reply

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.